Correlation Between Microsoft and MAINZ BIOMED

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and MAINZ BIOMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and MAINZ BIOMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and MAINZ BIOMED BV, you can compare the effects of market volatilities on Microsoft and MAINZ BIOMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of MAINZ BIOMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and MAINZ BIOMED.

Diversification Opportunities for Microsoft and MAINZ BIOMED

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Microsoft and MAINZ is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and MAINZ BIOMED BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAINZ BIOMED BV and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with MAINZ BIOMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAINZ BIOMED BV has no effect on the direction of Microsoft i.e., Microsoft and MAINZ BIOMED go up and down completely randomly.

Pair Corralation between Microsoft and MAINZ BIOMED

Assuming the 90 days trading horizon Microsoft is expected to generate 0.18 times more return on investment than MAINZ BIOMED. However, Microsoft is 5.59 times less risky than MAINZ BIOMED. It trades about 0.24 of its potential returns per unit of risk. MAINZ BIOMED BV is currently generating about -0.01 per unit of risk. If you would invest  40,175  in Microsoft on September 15, 2024 and sell it today you would earn a total of  2,440  from holding Microsoft or generate 6.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Microsoft  vs.  MAINZ BIOMED BV

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Microsoft may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MAINZ BIOMED BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAINZ BIOMED BV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, MAINZ BIOMED is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Microsoft and MAINZ BIOMED Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and MAINZ BIOMED

The main advantage of trading using opposite Microsoft and MAINZ BIOMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, MAINZ BIOMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAINZ BIOMED will offset losses from the drop in MAINZ BIOMED's long position.
The idea behind Microsoft and MAINZ BIOMED BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges